Company / Shareholders' Equity
IMMUCELL CORP /DE/ Shareholders' Equity History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$27.5M
FY2025
5-year range
$10.6M / $30.4M
FY2021-FY2025
Trend
+10.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $9M in FY2013 to $30M in FY2023.
Based on SEC 10-K filings.
$28M in FY2025 with a 10-year CAGR of +11.5%.
Declined from $30M to $28M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +11.5%
Key checks
Key Insights
- In FY2025, shareholders' equity increased 10.1% year-over-year.
- Peak shareholders' equity was recorded in FY2023.
- Lowest shareholders' equity in the period was in FY2013.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.5M | +10.1% |
| FY2024 | $25.0M | -17.7% |
| FY2023 | $30.4M | +54.0% |
| FY2017 | $19.7M | +85.8% |
| FY2016 | $10.6M | +14.6% |
| FY2015 | $9.3M | +0.7% |
| FY2014 | $9.2M | +1.9% |
| FY2013 | $9.0M | -2.8% |
| FY2012 | $9.3M | -3.5% |
| FY2011 | $9.6M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026